Spero Therapeutics, Inc.
NASDAQ:SPRO · NASDAQ Global Select
+$0.08 today
Vol 7.11M · Avg 0.78M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-22.18%
Period High
$3.04
Period Low
$1.83
Latest
$2.28
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Opus Genetics, Inc.
NASDAQ:IRD
$335.61M
TuHURA Biosciences, Inc.
NASDAQ:HURA
$149.97M
Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS
$137.20M
Cognition Therapeutics, Inc.
NASDAQ:CGTX
$104.12M
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
$102.16M
Seer, Inc.
NASDAQ:SEER
$94.84M
Seres Therapeutics, Inc.
NASDAQ:MCRB
$61.98M
Inovio Pharmaceuticals, Inc.
NASDAQ:INO
$58.41M
Actuate Therapeutics Inc
NASDAQ:ACTU
$50.24M
VistaGen Therapeutics, Inc.
VTGN
$22.74M
What is the latest SPRO filing?
The latest filing shown is 8-K dated May 13, 2026.
How many recent filings does SPRO have?
Intrinsic Alpha currently shows 20 recent filings for SPRO.
Explore More
Continue the stock analysis
Jump to another research area for this company.